Ischaemic stroke in young adults: predictors of outcome and recurrence

K Nedeltchev, T A der Maur, D Georgiadis, M Arnold, V Caso, H P Mattle, G Schroth, L Remonda, M Sturzenegger, U Fischer, R W Baumgartner, K Nedeltchev, T A der Maur, D Georgiadis, M Arnold, V Caso, H P Mattle, G Schroth, L Remonda, M Sturzenegger, U Fischer, R W Baumgartner

Abstract

Background: There is limited information about predictors of outcome and recurrence of ischaemic stroke affecting young adults.

Objective: To assess the predictive value of the presenting characteristics for both outcome and recurrence in young stroke victims.

Methods: Clinical and radiological data for 203 patients aged 16 to 45 years were collected prospectively; they comprised 11% of 1809 consecutive patients with ischaemic stroke. The National Institutes of Health stroke scale (NIHSS), the Bamford criteria, and the trial of ORG 10172 in acute stroke treatment (TOAST) classification were used to define stroke severity, subtype, and aetiology. The clinical outcome of 198 patients (98%) was assessed using the modified Rankin scale (mRS) and categorised as favourable (score 0-1) or unfavourable (score 2-6).

Results: Stroke was caused by atherosclerotic large artery disease in 4%, cardioembolism in 24%, small vessel disease in 9%, another determined aetiology in 30%, and undetermined aetiology in 33%. Clinical outcome at three months was favourable in 68%, unfavourable in 29%, and lethal in 3%. Thirteen non-fatal stroke, two fatal strokes, and six transient ischaemic attacks (TIA) occurred during a mean (SD) follow up of 26 (17) months. High NIHSS score, total anterior circulation stroke, and diabetes mellitus were independent predictors of unfavourable outcome or death (p<0.0001, p = 0.011, and p = 0.023). History of TIA predicted stroke recurrence (p = 0.02).

Conclusions: Severe neurological deficits at presentation, total anterior circulation stroke, and diabetes mellitus predict unfavourable outcome. Previous TIA are associated with increased risk of recurrence.

References

    1. Stroke. 1999 Nov;30(11):2320-5
    1. Stroke. 1996 May;27(5):838-41
    1. Stroke. 2001 Jan;32(1):52-6
    1. JAMA. 2000 Dec 13;284(22):2901-6
    1. N Engl J Med. 2001 Nov 15;345(20):1444-51
    1. Neurology. 2002 Jul 9;59(1):26-33
    1. Stroke. 2002 Jul;33(7):1828-33
    1. J Neurol. 2002 Jul;249(7):888-95
    1. Stroke. 2002 Aug;33(8):2105-8
    1. N Engl J Med. 2002 Nov 21;347(21):1713-6
    1. Stroke. 2002 Dec;33(12):2789-93
    1. Cerebrovasc Dis. 2003;15(1-2):121-8
    1. Bull World Health Organ. 1980;58(1):113-30
    1. Stroke. 1997 Sep;28(9):1702-9
    1. Cerebrovasc Dis. 1998 Sep-Oct;8(5):296-302
    1. Stroke. 1988 May;19(5):604-7
    1. Stroke. 1988 Aug;19(8):977-81
    1. Stroke. 1988 Sep;19(9):1083-92
    1. Stroke. 1989 Jul;20(7):871-5
    1. Lancet. 1991 Jun 22;337(8756):1521-6
    1. J Clin Epidemiol. 1992 Dec;45(12):1383-9
    1. Stroke. 1993 Jan;24(1):35-41
    1. Stroke. 1994 Jul;25(7):1360-5
    1. Stroke. 1994 Aug;25(8):1611-6
    1. Arch Neurol. 1995 May;52(5):491-5
    1. Ann Acad Med Singapore. 1995 Jan;24(1):172-6
    1. JAMA. 1999 Dec 1;282(21):2003-11

Source: PubMed

3
구독하다